Turkey will initially receive 550,000 doses of the vaccine but the number of delivered units will reach 4.5 million by the end of March, Daily Sabah quoted Koca as saying on Friday.
BioNTech developed the vaccine together with U.S. pharmaceutical company Pfizer.
As of Sunday, Turkey has registered 2.15 million Covid-19 cases, including 19,878 deaths since the start of the pandemic.